Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

75.25 +0.48 (+0.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
49 50 Next >
News headline image
Expert Ratings For DexCom ↗
 
Via Benzinga
News headline image
Don't overlook NASDAQ:DXCM—a stock with solid growth prospects and a reasonable valuation. ↗
Investors should take note ofDEXCOM INC (NASDAQ:DXCM), a growth stock that remains attractively priced. 
Via Chartmill
News headline image
MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs
With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs. 
Via MarketBeat
Topics Earnings
News headline image
3 Mid-Cap Stocks Poised for a Breakout in 2024 ↗
Mid-cap stocks are expected to have a breakout year especially in light of their underperformance in 2023 with these equities looking strong. 
Via InvestorPlace
News headline image
The 3 Best Growth Stocks to Buy in January 2024 ↗
The best growth stocks to buy for 2024 with an impressive growth history and solid long-term tailwinds to support 30% EPS growth. 
Via InvestorPlace
News headline image
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. 
Via Investor's Business Daily
Topics ETFs
News headline image
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
2 Growth Stocks That Could Make You Richer in 2024 and Beyond ↗
Last year wasn't great for either stock, but that's no reason to ignore them. 
Via The Motley Fool
News headline image
History Says the Nasdaq Will Soar in 2024: 1 Stock-Split AI Growth Stock to Buy Now and Hold Forever ↗
Nvidia is well positioned to create value for patient shareholders, given its leadership in artificial intelligence chips. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Stocks to Capitalize on the Telehealth Explosion ↗
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic. 
Via InvestorPlace
News headline image
Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales ↗
Dexcom beat fourth-quarter sales expectations and issued stronger-than-usual annual guidance. 
Via Investor's Business Daily
News headline image
A Closer Look at DexCom's Options Market Dynamics ↗
 
Via Benzinga
News headline image
Is NASDAQ:DXCM a Fit for Growth Investing Strategies? ↗
Should you consider DEXCOM INC (NASDAQ:DXCM) for growth investing? 
Via Chartmill
News headline image
The Latest Analyst Ratings For DexCom ↗
 
Via Benzinga
News headline image
DexCom Unusual Options Activity ↗
 
Via Benzinga
News headline image
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
From DexCom, Inc.
Via Business Wire
News headline image
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
News headline image
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation. ↗
Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
News headline image
1 Stock-Split Stock to Buy Hand Over Fist in 2024 and 1 to Avoid ↗
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer that's ripe for the picking, as well as an... 
Via The Motley Fool
News headline image
Looking Into DexCom's Recent Short Interest ↗
 
Via Benzinga
News headline image
$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today ↗
 
Via Benzinga
News headline image
For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering. ↗
NASDAQ:DXCM stands out as a growth opportunity that won't break the bank. 
Via Chartmill
News headline image
These 3 Companies Can Be the Next Stock-Split Stocks in 2024 ↗
Since mid-2021, Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk have conducted stock splits. Three well-known companies look set to follow in... 
Via The Motley Fool
News headline image
Meet the Stock-Split Stock Warren Buffett Is Likeliest to Buy in 2024 ↗
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a stock-split stock that checks all the right boxes for the Oracle of Omaha. 
Via The Motley Fool
News headline image
3 Stock-Split Stocks Billionaires Are Piling Into Ahead of 2024 ↗
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry leaders Wall Street's brightest money managers want to own for... 
Via The Motley Fool
News headline image
DexCom's Options Frenzy: What You Need to Know ↗
 
Via Benzinga
News headline image
DEXCOM INC (NASDAQ:DXCM) showing high EPS and FCF growth while beating expectations ↗
DEXCOM INC (NASDAQ:DXCM) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
News headline image
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
News headline image
3 Stock-Split Stocks With 51% to 128% Upside in 2024, According to Select Wall Street Analysts ↗
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three high-flying stocks a trio of Wall Street analysts believe can soar in the... 
Via The Motley Fool
News headline image
Pet Parents Keep Spending ↗
We also talk with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes care. 
Via The Motley Fool
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.